Sustained SREBP-1-dependent lipogenesis as a key mediator of resistance to BRAF-targeted therapy

Bibliographic Details
Title: Sustained SREBP-1-dependent lipogenesis as a key mediator of resistance to BRAF-targeted therapy
Authors: Ali Talebi, Jonas Dehairs, Florian Rambow, Aljosja Rogiers, David Nittner, Rita Derua, Frank Vanderhoydonc, Joao A. G. Duarte, Francesca Bosisio, Kathleen Van den Eynde, Kris Nys, Mónica Vara Pérez, Patrizia Agostinis, Etienne Waelkens, Joost Van den Oord, Sarah-Maria Fendt, Jean-Christophe Marine, Johannes V. Swinnen
Source: Nature Communications, Vol 9, Iss 1, Pp 1-11 (2018)
Publisher Information: Nature Portfolio, 2018.
Publication Year: 2018
Collection: LCC:Science
Subject Terms: Science
More Details: Melanoma patients harbouring BRAFV600E mutation generally develop resistance to targeted therapy. In this study, the authors demonstrate that SREBP-1-mediated induction of lipid biosynthesis contributes to therapy resistance in BRAF mutant melanoma.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2041-1723
Relation: https://doaj.org/toc/2041-1723
DOI: 10.1038/s41467-018-04664-0
Access URL: https://doaj.org/article/c1bb7bfd70be4f42827f1d7f1e16991f
Accession Number: edsdoj.1bb7bfd70be4f42827f1d7f1e16991f
Database: Directory of Open Access Journals
More Details
ISSN:20411723
DOI:10.1038/s41467-018-04664-0
Published in:Nature Communications
Language:English